AMGN — All updates

4 entries loaded; 0 direction changes

Filter loaded records
“NVDA Fallout: Where Is the Smart Money Going? | Market Pulse Nov. 13, 2026”
$AMGNBullish
AI summary · AMGN's compressed-spring chart pattern is a reason the speaker expects a rise, since market makers keep it ranged before moving it upward; the move still needs a strong push from the market. He notes AMGN is not collapsing in a weak market and calls it a good stock, while saying we will see.

So let me review Amgen's stock. I'm going to enlarge the graph so you can see it a little more clearly. Amgen stock. Look at that. So Amgen is in a state of compromise, which is what I talked about in my last video.

She talked about Apple and Amgen. And here we are. The arrow gathers like a compressed spring. In my opinion, the compressed spring is a reason for the rise, because market makers keep it within a certain range before they jump it upwards.

We'll see. It needs a strong push from the market to get there, but it doesn't collapse in this weak market. It's a good stock, isn't it?

“AAPL & AMGN in the Buy Zone: 2 Stocks Ready to Break Out?”
$AMGNBullish
AI summary · AMGN is in a buy zone after a double-bottom base atop a long cup base, breaking out for 3 weeks without leaving the zone; it is above the 50-day, 21-day and 200-day moving averages and looks like an early-stage base poised to rise. Recent earnings rose 14% (decent, not spectacular), with steady EPS growth of 7% a year and sales growth of 12% a year (pretty good, not amazing), and an 84 strength rating. The speaker would buy near the current price and sell slightly out-of-the-money December covered calls for about a 3.2% premium.

The first one is Amgen. So, I want to look at Amgen here. And so Amgen right now is showing a um on a weekly on a weekly base. Let me blow this up for you. Uh on a weekly base, you can see it is in a buy zone here off a double bottom base.

And the double bottom bases on top of this cup base. So we've got a big long consolidation base right in here. And you can see it broke out and has been breaking out for the last 3 weeks, but it hasn't pulled away from the buy zone.

This little green zone right here is the buy zone.

David Lin Published 2026-09-27
“‘Almost 0%’ Chance Stocks Are Higher In 10 Years | Bill Smead”
$AMGNBullish
AI summary · Owns AMGN; values its conservative accounting where 18-20% of revenue is spent on R&D and expensed upfront rather than depreciated.

we own Merc and Amgen, and we love those companies because they have the most conservative accounting of any major corporations. What do I mean by that? They spend 18 to 20% of of their revenue each year on R&D and expense it upfront.

Expense it. They don't depreciate. It's the most important long-term investment they make. So, their income statement, they are actually much more profitable as compared to other corporations because of how conservative their accounting is.

That's the earliest record
All updates for other tickers
Follow $AMGN30-day free trial
Start trial